CLS applauds yesterday’s decision by the Supreme Court to uphold the FDA’s review and approval authority for new medicines

CLS applauds yesterday’s decision by the Supreme Court to uphold the FDA’s review and approval authority for new medicines. The importance of regulatory certainty cannot be overstated for our innovative member organizations to bring new treatments and cures to patients. This decision ensures that FDA continues to be the gold standard when it comes to drug approvals.